JRCALC Updates 2019:

Clopidogrel – REMOVED

Description:

This medicine has been removed from JRCALC, as a result of the ACS guideline review. Follow local policies/guidelines for P2Y12 inhibitor antiplatelet agents (e.g. ticagrelor, prasugrel).

Date Update Posted Online: January 9, 2023

View all Updates

Search Updates

The JRCALC logo
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.